Evolving Technology Platforms in Pharma-Biotech (TechVision) - Industry Analysis, Trends, Technologies & Opportunities

Dec 11, 2015, 09:15 ET from Research and Markets

DUBLIN, December 11, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/md8l28/evolving) has announced the addition of the "Evolving Technology Platforms in Pharma-Biotech (TechVision)" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This comprehensive report provides a detailed understanding of the evolving technology platforms in the pharma-biotech industry, offer readers an in-depth analysis of the key topics all market participants should be aware of. It considers current and future factors expected to play a part in this market's development. It also considers the various drivers, challenges and opportunities of the industry. 

Groundbreaking advances in the scientific understanding of the underlying mechanisms of disease are paving the way for precision medicine for the upcoming years. Indeed, the promise of personalized medicine is becoming a reality generating notable improvements in human health and the potential to reduce the socioeconomic burden of disease. This research service (RS) depicts the current landscape of biopharmaceutical development, focusing on medicines that have progressed beyond early stage development and have recently entered clinical testing in human volunteers or first-in-human studies. 

The continued development of new treatments associated with the demographic trends and public health considerations is essential. The biopharmaceutical industry is one of the most research intensive sectors in developed nations. Investments are more than USD 125 billion, especially in early stages development phases, including the processes of discovering and developing new medicines. Biopharmaceutical innovation has played a major role in the improvement of both length and quality of life during the past decade, considerably reducing the disease burden for individuals and the society.

The RS also includes: R&D portfolio and budgetary analysis Environmental analysis, depicting the key technical challenges, key business challenges, and emerging market needs Industry best practices and strategic insights, measuring performance, assessment of partnerships and alliances and R&D pipeline by milestones Strategic evaluation of R&D portfolio

Report Structure:

1. Executive Summary 

2. Drug Discovery and Development A Sneak Preview 

3. Strategic Assessment of the Industry Environment 

4. Benchmarking Model and Assumptions 

5. Case Representative Studies:AbbVie - Amgen - Bayer - Roche 

For more information visit http://www.researchandmarkets.com/research/md8l28/evolving

About Research and Markets: 

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Laura Wood

SOURCE Research and Markets